ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancerEunju Kim, Zheng Chen, Jin Muk Kang et al.|Cell Death and Disease|2022Cited by 68
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Ji Young Yoo, Jin Muk Kang et al.|Neuro-Oncology|2024Cited by 22